Literature DB >> 7529479

Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells.

K Hamann1, J Grabbe, P Welker, N Haas, B Algermissen, B M Czarnetzki.   

Abstract

In order to evaluate various markers for human mast cells, two human mast/basophilic cell lines (HMC-1/KU812), cultured mast cells from the peripheral blood monocytic fraction and peripheral blood monocytes were compared with mast cells in tissue sections from normal skin, using histochemistry, enzyme histochemistry and immunohistochemistry. All reagents stained normal skin mast cells, with toluidine blue, tryptase reactivity and antibodies against the Fc epsilon RI and the stem cell factor receptor (c-kit) being most active. The cell lines and mast cells cultured from peripheral blood were negative for avidin, safranin and chymase, strongly positive for c-kit and variably reactive with all other reagents. All antibodies except AA1 against tryptase also stained one or several epidermal and dermal cell types or blood monocytes. Histochemical stains (toluidine blue, avidin) and reagents for the enzymes tryptase and chymase are thus specific markers for mast cells. The frequent reactivity of antibodies against mast cells with other cell types indicates interesting functional and ontogenetic relationships between these cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529479     DOI: 10.1007/bf00371797

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  35 in total

1.  High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies.

Authors:  F Riske; J Hakimi; M Mallamaci; M Griffin; B Pilson; N Tobkes; P Lin; W Danho; J Kochan; R Chizzonite
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

Review 2.  Mast cell heterogeneity.

Authors:  A M Irani; L B Schwartz
Journal:  Clin Exp Allergy       Date:  1989-03       Impact factor: 5.018

Review 3.  Recent advances in the cellular and molecular biology of mast cells.

Authors:  R L Stevens; K F Austen
Journal:  Immunol Today       Date:  1989-11

4.  Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties.

Authors:  L Enerbäck
Journal:  Acta Pathol Microbiol Scand       Date:  1966

5.  Intraepithelial migration of nasal mucosal mast cells in hay fever.

Authors:  L Enerbäck; U Pipkorn; G Granerus
Journal:  Int Arch Allergy Appl Immunol       Date:  1986

6.  Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin.

Authors:  J Grabbe; N Haas; K Hamann; G Kolde; J Hakimi; B M Czarnetzki
Journal:  Br J Dermatol       Date:  1993-08       Impact factor: 9.302

7.  Basophils in allergen-induced patch test sites in atopic dermatitis.

Authors:  E B Mitchell; J Crow; M D Chapman; S S Jouhal; F M Pope; T A Platts-Mills
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

8.  A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors.

Authors:  K Kishi
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

9.  Heterogeneity of human mast cells.

Authors:  E S Schulman; A Kagey-Sobotka; D W MacGlashan; N F Adkinson; S P Peters; R P Schleimer; L M Lichtenstein
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

10.  The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells.

Authors:  P de Vries; K A Brasel; J R Eisenman; A R Alpert; D E Williams
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  13 in total

1.  A subclone (5C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line.

Authors:  S Weber; M Babina; S Krüger-Krasagakes; A Grützkau; B M Henz
Journal:  Arch Dermatol Res       Date:  1996-11       Impact factor: 3.017

2.  Adhesion molecules on the human mast cell line HMC-1 are upregulated during cell activation.

Authors:  S Weber; B Ruh; S Krüger-Krasagakes; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

3.  Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells.

Authors:  P Welker; J Grabbe; B Gibbs; T Zuberbier; B M Henz
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

4.  Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206.

Authors:  A Grützkau; S Krüger-Krasagakes; H Baumeister; C Schwarz; H Kögel; P Welker; U Lippert; B M Henz; A Möller
Journal:  Mol Biol Cell       Date:  1998-04       Impact factor: 4.138

5.  Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.

Authors:  N Haas; K Hamann; J Grabbe; B Algermissen; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Comparative cytokine gene expression: regulation and release by human mast cells.

Authors:  A Möller; B M Henz; A Grützkau; U Lippert; Y Aragane; T Schwarz; S Krüger-Krasagakes
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

7.  Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1).

Authors:  P Welker; J Grabbe; A Grützkau; B M Henz
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

Review 8.  Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes.

Authors:  J Grabbe; P Welker; E Dippel; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

9.  Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.

Authors:  P Welker; D Schadendorf; M Artuc; J Grabbe; B M Henz
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

10.  High abundances of neurotrophin 3 in atopic dermatitis mast cell.

Authors:  David Quarcoo; Tanja C Fischer; Nora Peckenschneider; David A Groneberg; Pia Welker
Journal:  J Occup Med Toxicol       Date:  2009-04-22       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.